| 10988498 |
Processes and intermediates for the preparation of 1′-substituted carba-nucleoside analogs |
Thomas Butler, Aesop Cho, Benjamin R. Graetz, Samuel E. Metobo, Oliver L. Saunders +3 more |
2021-04-27 |
$236,030,000 |
| 10023600 |
Processes and intermediates for the preparation of 1′-substituted carba-nucleoside analogs |
Thomas Butler, Aesop Cho, Benjamin R. Graetz, Samuel E. Metobo, Oliver L. Saunders +3 more |
2018-07-17 |
$510,065,000 |
| 9981955 |
Antiviral compounds |
Elizabeth M. Bacon, Eda Canales, Aesop Cho, Jeromy J. Cottell, Manoj C. Desai +23 more |
2018-05-29 |
|
| RE46762 |
1′-substituted carba-nucleoside analogs for antiviral treatment |
Thomas Butler, Aesop Cho, Jay P. Parrish, Oliver L. Saunders, Lijun Zhang |
2018-03-27 |
|
| 9511056 |
Antiviral compounds |
Elizabeth M. Bacon, Eda Canales, Aesop Cho, Jeromy J. Cottell, Manoj C. Desai +23 more |
2016-12-06 |
|
| 9139604 |
Antiviral phosphonate analogs |
Constantine G. Boojamra, Carina E. Cannizzaro, James M. Chen, Xiaowu Chen, Aesop Cho +18 more |
2015-09-22 |
$337,260,000 |
| 8927484 |
Antiviral compounds |
Zhenhong R. Cai, Michael O'Neil Hanrahan Clarke, Edward Doerffler, Mingzhe Ji, Hyung-Jung Pyun +2 more |
2015-01-06 |
$372,891,000 |
| 8877733 |
1′-substituted pyrimidine N-nucleoside analogs for antiviral treatment |
Aesop Cho, Thorsten A. Kirschberg, Michael R. Mish, Neil H. Squires |
2014-11-04 |
$472,289,000 |
| 8871785 |
Antiviral phosphonate analogs |
Constantine G. Boojamra, Carina E. Cannizzaro, James M. Chen, Xiaowu Chen, Aesop Cho +18 more |
2014-10-28 |
$518,238,000 |
| 8853171 |
1′-substituted carba-nucleoside analogs for antiviral treatment |
Thomas Butler, Aesop Cho, Jay P. Parrish, Oliver L. Saunders, Lijun Zhang |
2014-10-07 |
$511,758,000 |
| 8841278 |
Antiviral compounds |
Elizabeth M. Bacon, Eda Canales, Aesop Cho, Jeromy J. Cottell, Manoj C. Desai +23 more |
2014-09-23 |
|
| 8822430 |
Antiviral compounds |
Elizabeth M. Bacon, Eda Canales, Aesop Cho, Jeromy J. Cottell, Manoj C. Desai +23 more |
2014-09-02 |
|
| 8809266 |
Antiviral compounds |
Aesop Cho, Michael O'Neil Hanrahan Clarke, John O. Link, Hyung-Jung Pyun, Xiaoning C. Sheng +1 more |
2014-08-19 |
$228,809,000 |
| 8765722 |
Inhibitors of flaviviridae viruses |
Aesop Cho, Lee S. Chong, Michael O'Neil Hanrahan Clarke, Edward Doerffler, Qi Liu +2 more |
2014-07-01 |
$825,281,000 |
| 8674088 |
Antiviral phosphinate compounds |
Anthony Casarez, Kleem Chaudhary, Aesop Cho, Michael O'Neil Hanrahan Clarke, Edward Doerffler +4 more |
2014-03-18 |
$231,520,000 |
| 8586744 |
Antiviral phosphinate compounds |
Anthony Casarez, Kleem Chaudhary, Aesop Cho, Michael O'Neil Hanrahan Clarke, Edward Doerffler +4 more |
2013-11-19 |
$308,376,000 |
| 8575118 |
Antiviral compounds |
Hongyan Guo, Darryl Kato, Thorsten A. Kirschberg, Hongtao Liu, John O. Link +23 more |
2013-11-05 |
$204,371,000 |
| 8501714 |
Inhibitors of Flaviviridae viruses |
Aesop Cho, Lee S. Chong, Michael O'Neil Hanrahan Clarke, Edward Doerffler, Qi Liu +2 more |
2013-08-06 |
$561,425,000 |
| 8476225 |
Antiviral compounds |
Anthony Casarez, Mingzhe Ji, Xiaoning C. Sheng, Qiaoyin Wu |
2013-07-02 |
$264,005,000 |
| 8455451 |
2'-fluoro substituted carba-nucleoside analogs for antiviral treatment |
Aesop Cho, Adrian S. Ray |
2013-06-04 |
$503,240,000 |
| 8420597 |
Antiviral compounds |
Aesop Cho, Michael O'Neil Hanrahan Clarke, John O. Link, Hyung-Jung Pyun, Xiaoning C. Sheng +1 more |
2013-04-16 |
$532,026,000 |
| 8415308 |
1′-substituted-carba-nucleoside prodrugs for antiviral treatment |
Aesop Cho, Adrian S. Ray, Lijun Zhang |
2013-04-09 |
$556,503,000 |
| 8354421 |
HIV reverse transcriptase inhibitors |
Gong-Xin He, Michael L. Mitchell, Lianhong Xu |
2013-01-15 |
|
| 8334295 |
Pyrimidine derivatives as HIV reverse transcriptase inhibitors |
Hongyan Guo, Ill Young Lee, Michael L. Mitchell, Gerry Rhodes, Jong Chan Son +1 more |
2012-12-18 |
|
| 8329727 |
Imidazo[4,5-c]pyridine compounds and methods of antiviral treatment |
Steven S. Bondy, Eric Dowdy, David A. Oare, Johan Neyts, Vahid Zia +1 more |
2012-12-11 |
$228,648,000 |
